Leung J C, Poon P Y, Lai K N
Department of Medicine, Queen Mary Hospital, University of Hong Kong.
J Lab Clin Med. 1999 Feb;133(2):152-60. doi: 10.1016/s0022-2143(99)90008-2.
Immunoglobulin A nephropathy (IgAN) is characterized by raised serum IgA and predominant mesangial IgA deposits of polymeric nature. The abnormal glycosylation of the carbohydrate moieties in the hinge region of the IgA molecule has recently attracted much attention. In this study we investigated the galactosylation and sialylation of monomeric and polymeric IgA1 isolated from patients with IgAN. Total IgA1 in serum samples from patients with IgAN or from healthy controls was isolated with a jacalin-agarose column as jacalin-bound protein (JBP). Monomeric and polymeric IgA1 were distinctly separated by fast protein liquid chromatography. Lectin binding assays were designed to examine the sialylation and the expression of terminal galactose and N-acetyl galactosamine of the O-linked carbohydrate in the hinge region of the IgA molecule. Reduced terminal galactosylation was demonstrated in serum IgA and monomeric IgA1 isolated from patients with IgAN as compared with results in healthy control subjects. However, a reduction in terminal galactosylation was not found in polymeric IgA1 isolated from patients with IgAN. Instead, increased sialylation of IgA1 (alpha2-3 linked to galactose) was demonstrated in polymeric IgA1. This abnormality of IgA1 could bear considerable implication on the pathogenesis of IgAN, because the masking effect of sialic acid may hinder the clearance of polymeric IgA1 by the asialoglycoprotein receptor (ASGP-R) of the liver cells. An increase in the sialylated content would also render the polymeric IgA from patients with IgAN more anionic. These immunochemical properties may contribute to the selective glomerular deposition of polymeric IgA1 in IgAN.
免疫球蛋白A肾病(IgAN)的特征是血清IgA升高以及以聚合形式为主的系膜IgA沉积。IgA分子铰链区碳水化合物部分的异常糖基化最近备受关注。在本研究中,我们调查了从IgAN患者分离出的单体和聚合IgA1的半乳糖基化和唾液酸化情况。通过用红豆蔻凝集素 - 琼脂糖柱作为与红豆蔻结合的蛋白(JBP)来分离IgAN患者或健康对照者血清样本中的总IgA1。通过快速蛋白质液相色谱法将单体和聚合IgA1明显分离。设计凝集素结合试验以检查IgA分子铰链区O - 连接碳水化合物的唾液酸化以及末端半乳糖和N - 乙酰半乳糖胺的表达。与健康对照者的结果相比,从IgAN患者分离出的血清IgA和单体IgA1中显示出末端半乳糖基化减少。然而,在从IgAN患者分离出的聚合IgA1中未发现末端半乳糖基化减少。相反,在聚合IgA1中显示出IgA1(α2 - 3连接到半乳糖)的唾液酸化增加。IgA1的这种异常可能对IgAN的发病机制有重要影响,因为唾液酸的掩盖作用可能会阻碍肝细胞的去唾液酸糖蛋白受体(ASGP - R)对聚合IgA1的清除。唾液酸化含量的增加也会使IgAN患者的聚合IgA带更多负电荷。这些免疫化学特性可能有助于聚合IgA1在IgAN中选择性地沉积于肾小球。